For the quarter ending 2026-03-31, ACTU has $8,911,286 in assets. $5,126,888 in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 8,134,004 | 13,159,423 | 16,924,763 | 6,492,656 |
| Prepaid assets and other current assets | 385,444 | 483,996 | 519,237 | 195,903 |
| Total current assets | 8,519,448 | 13,643,419 | 17,444,000 | 6,688,559 |
| Deferred offering costs and other assets | 391,838 | 392,491 | 269,934 | 280,342 |
| Total assets | 8,911,286 | 14,035,910 | 17,713,934 | 6,968,901 |
| Accrued compensation | - | 588,304 | 846,283 | 1,388,118 |
| Accounts payable | 1,201,393 | 1,524,190 | 1,245,375 | 3,171,015 |
| Other accrued expenses | 2,602,611 | 3,567,404 | 4,259,048 | 4,570,631 |
| Accrued compensation | 885,813 | - | - | - |
| Accrued interest, current | 32,080 | 27,018 | 21,956 | 70,957 |
| Total current liabilities | 4,721,897 | 5,706,916 | 6,372,662 | 9,200,721 |
| Accrued interest, less current portion | - | 0 | 0 | 16,893 |
| License payable | 404,991 | 404,991 | 404,991 | 404,991 |
| Total long-term liabilities | 404,991 | 404,991 | 404,991 | 421,884 |
| Total liabilities | 5,126,888 | 6,111,907 | 6,777,653 | 9,622,605 |
| Common stock, 0.000001 par value, 200,000,000 shares authorized, 23,711,677 and 23,245,203 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively, | 24 | 23 | 23 | 20 |
| Additional paid-in capital | 164,017,824 | 162,531,681 | 160,990,006 | 141,992,554 |
| Accumulated deficit | -160,233,450 | -154,607,701 | -150,053,748 | -144,646,278 |
| Total stockholders equity | 3,784,398 | 7,924,003 | 10,936,281 | -2,653,704 |
| Total liabilities and stockholders equity | 8,911,286 | 14,035,910 | 17,713,934 | 6,968,901 |
ACTUATE THERAPEUTICS, INC. (ACTU)
ACTUATE THERAPEUTICS, INC. (ACTU)